Drugs / AC102
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05776459 | Oct 2022 → Feb 2026 overdue | sensorineural hearing loss disorder | AudioCure Pharma GmbH | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05776459 ↗ |
| Route | Other | “AC102 Single intratympanic injection” NCT05776459 ↗ |